Oral decontamination to prevent ventilator-associated pneumonia: Is it a sound strategy?

Chest

Volumn 135, Issue 5, 2009, Pages 1116-1118

  Dallas, John ^a   Kollef, Marin ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CHLORHEXIDINE; ISEGANAN; PLACEBO; POVIDONE IODINE;

ANTIBIOTIC THERAPY; APACHE; ARTIFICIAL VENTILATION; CLINICAL TRIAL; COMORBIDITY; EDITORIAL; HOSPITAL INFECTION; HUMAN; INFECTION PREVENTION; INTENSIVE CARE UNIT; MORTALITY; MOUTH HYGIENE; PRIORITY JOURNAL; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 65949105913     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-2757     Document Type: Editorial

References (13)

1. American Thoracic Society. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416 (Pubitemid 40227463)
2. D'Amico R, Pifferi S, Leonetti C, et al. Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomized controlled trials. BMJ 1998; 316:1275-1285
3. Nathens AB, Marshall JC. Selective decontamination of the digestive tract in surgical patients: a systematic review of the evidence. Arch Surg 1999; 134:170-176 (Pubitemid 29088969)
4. deSmet AMGA, Kluytmans JAJW, Cooper BS, et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 2009;360:20-31
5. Chan E, Ruest A, Meade M, et al. Oral decontamination for prevention of pneumonia in mechanically ventilated adults: systematic review and meta-analysis. BMJ 2007; 334:889-900
6. Kollef M, Pittet D, Garcia MS, et al. A randomized double-blind trial of iseganan in prevention of ventilator-associated pneumonia. Am J Respir Crit Care Med 2006; 173:91-97 (Pubitemid 43069793)
7. Seguin P, Tanguy M, Laviolle B, et al. Effect of oropharyngeal decontamination by povidone-iodine on ventilator-associated pneumonia in patients with head trauma. Crit Care Med 2006; 34:1514-1519 (Pubitemid 43754577)
8. Chlebicki MP, Safdar N. Topical chlorhexidine for prevention of ventilator-associated pneumonia: a meta-analysis. Crit Care Med 2007; 35:595-602 (Pubitemid 46148554)
9. Pineda L, Saliba R, El Solh A. Effect of oral decontamination with chlorhexidine on the incidence of nosocomial pneumonia: a meta-analysis. Critical Care 2006; 10:R35 (Pubitemid 47079786)
10. Koeman M, van der Ven AJ, Hak E, et al. Oral decontamination with chlorhexidine reduces the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med 2006; 173:1348-1355 (Pubitemid 43900709)
11. Tantipong H, Morkchareonpong C, Jaiyindee S, et al. Randomized controlled trial and meta-analysis of oral decontamination with 2% chlorhexidine solution for the prevention of ventilator-associated pneumonia. Infect Control Hosp Epidemiol 2008; 29:131-136
12. Panchabhai TS, Dangayach NS, Krishnan A, et al. Oropharyngeal cleansing with 0.2% chlorhexidine for prevention of nosocomial pneumonia in critically ill patients: an open-label randomized trial with 0.01% potassium permanganate as control. Chest 2009; 135:1150-1156
13. Kollef MH, Afessa B, Anzueto A, et al. Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia. JAMA 2008; 300:805-813